首页> 外文OA文献 >PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS STANDARD CARE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN PORTUGAL

【2h】

PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS STANDARD CARE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN PORTUGAL

机译：PMS30在葡萄牙绝经后骨质疏松症治疗中的应用价值分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Cristino J.; Canhão H.; Perelman J.; Santos C.; Pereira J.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece [J] . Athanasakis Kostas, Tarantilis Filippos, Tsalapati Konstantina, Rheumatology international. . 2015,第9期

机译：在希腊，类风湿关节炎一线用托珠单抗单药治疗与护理标准的成本-效用分析
2. Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial [J] . Cosman Felicia, McMahon Donald, Dempster David, Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research . 2020,第2期

机译：标准对骨质疏松症的循环萜酯和Denosumab治疗：随机试验
3. Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial [J] . Trends in Ecology & Evolution . 2020,第2期

机译：标准对骨质疏松症的循环萜酯和Denosumab治疗：随机试验
4. Antiresorptive effect of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis [C] . M. A. Korolev, N. E. Banshchikova, E. A. Letjagina, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：地诺单抗对类风湿关节炎骨质疏松症的抗吸收作用
5. Impacto clínico y Coste-Utilidad Del Tratamiento De La Osteoporosis En Espa?a =Clinical impact and cost-utility of the osteoporosis treatment in Spain [D] . Osca Guadalajarara, Marta. 2021

机译：西班牙骨质疏松症治疗的临床影响及成本效用=西班牙骨质疏松症治疗的临床影响及成本效用
6. Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland [O] . Ewa Stawowczyk, Paweł Kawalec, Andrzej Pilc -1

机译：波兰溃疡性结肠炎一年内使用阿达木单抗/标准治疗和仅标准治疗治疗的成本效用分析
7. PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES [O] . Beaubrun A.C., Daugherty J.B. 2011

机译：PMS34与美罗华联合拉洛昔芬治疗美国绝经后妇女骨质疏松症的成本效用分析

PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS STANDARD CARE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN PORTUGAL

著录项

引文网络

相似文献

相关主题

期刊订阅